Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | CES2 | O00748 | 2/20 | 0.57 |
| ▸ | BCHE | P06276 | 2/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | APAF1 | O14727 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | GALK1 | P51570 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12205420 | 0.88 | MEN1 (0.53) | CES1ALDH1A1CES2BCHEMCL1 | |
| Acenaphthoquinone SCHEMBL19212172 | 0.86 | ALDH1A1 (0.77) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL23068382 | 0.82 | ALDH1A1 (0.56) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL31107074 | 0.82 | ALDH1A1 (0.56) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL5998053 | 0.82 | TYMS (0.60) | NPSR1MAPTATML3MBTL1MEN1 | |
| SCHEMBL17529466 | 0.81 | PARP1 (0.61) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL28017773 | 0.80 | ALDH1A1 (0.46) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL1232155 | 0.78 | PTPN1 (0.50) | ALDH1A1NPSR1MAPTATML3MBTL1 | |
| SCHEMBL28928974 | 0.77 | CES1 (0.40) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL28929001 | 0.77 | MEN1 (0.38) | CES1NPSR1MAPTATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| EP-2421809-B1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| WO-2010123153-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | CES1 1458/4885ALDH1A1 218/4885CES2 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.